Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | PTGES | O14684 | 14/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16671439 | 0.82 | PTGES (0.44) | PTGES | |
| SCHEMBL9898267 | 0.81 | EPHX2 (0.40) | CA1CA2CA7CA14PTGES | |
| SCHEMBL1671130 | 0.80 | EPHX2 (0.40) | CA1CA2CA7CA14PTGES | |
| SCHEMBL16670819 | 0.80 | PTGES (0.39) | CA1CA2CA7CA14PTGES | |
| SCHEMBL16682194 | 0.79 | ALOX5 (0.40) | PTGESHDAC6EPHX2NR1H4 | |
| SCHEMBL16671628 | 0.79 | ALOX5 (0.40) | PTGESHDAC6EPHX2NR1H4 | |
| SCHEMBL15539906 | 0.78 | PTGES (0.43) | CA1CA2CA7CA14PTGES | |
| SCHEMBL15540907 | 0.78 | CA1 (0.39) | CA1CA2CA7CA14PTGES | |
| SCHEMBL16682136 | 0.78 | CYP1A1 (0.46) | EPHX2NR1H4 | |
| SCHEMBL16670731 | 0.78 | DPP4 (0.39) | PTGESHDAC6EPHX2NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015059618-A1 | SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015059618-A1 | SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2015-04-30 | — | — | WO | disclosed |